ResearchMoz

Renal Dialysis Equipment - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018

GlobalData
Published Date » 2012-09-30
No. Of Pages » 149

Renal Dialysis Equipment Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018

GlobalDatas new report, Renal Dialysis Equipment Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018 provides key data, information and analysis on the global renal dialysis equipment market. The report provides market landscape, competitive landscape and market trends information on the renal dialysis equipment market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
  • Key segments covered include Hemodialysis Machines, Peritoneal Dialysis Solutions, Continuous Renal Replacement Therapy and Dialysis Accessories.
  • Annualized market revenue data from 2004 to 2011, forecast forward for seven years to 2018. Company share data for 2011.
  • Qualitative analysis of key market trends, market drivers, and restraints by each category within renal dialysis equipment market. 
  • The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies. 
  • Key players covered include Fresenius Medical Care, Baxter International, Gambro, NIPRO CORPORATION and B. Braun Melsungen. 

Reasons to buy

  • Develop business strategies by understanding the trends and developments that are driving the renal dialysis equipment market globally.
  • Design and develop your product development, marketing and sales strategies.
  • Develop market-entry and market expansion strategies.
  • Identify key players best positioned to take advantage of the emerging market opportunities.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Whats the next big thing in the renal dialysis equipment market landscape? Identify, understand and capitalize.
  • Make more informed business decisions from the insightful and in-depth analysis of the global renal dialysis equipment market and the factors shaping it.
Table of Contents

1 Table of Contents
1 Table of Contents 3
1.1 List of Tables 6
1.2 List of Figures 8

2 Introduction 10
2.1 GlobalData Report Guidance 10

3 Disease Overview - Renal Failure 11
3.1 Introduction 11
3.2 Types of Renal Failure 11
3.2.1 Classification of CRF 12
3.2.2 Risk Factors for CRF 13
3.2.3 Signs and Symptoms of CRF 14
3.2.4 Complications of CRF 15
3.2.5 Co-Morbid Conditions 15
3.3 ESRD 17
3.3.1 Causes of ESRD 17
3.4 Epidemiology of CRF and ESRD: Patient Numbers, Prevalence, Incidence, and Mortality Rate 18
3.4.1 Global 18
3.4.2 US 21
3.4.3 Canada 22
3.4.4 Europe 22
3.4.5 Asia and Australia 23
3.5 Treatment Options 24

4 Device-Based Treatment Modalities - Dialysis 25
4.1.1 Dialysis Machine 27
4.1.2 Types of Dialysis 27

5 Renal Dialysis Equipment - Global Market Characterization 37
5.1 Global Renal Dialysis Equipment Market, Revenue ($bn), Historic, 2004-2011 37
5.2 Global Renal Dialysis Equipment Market, Revenue ($bn), Forecast, 2011-2018 38
5.3 Global Renal Dialysis Equipment Market, Key Trends 39
5.3.1 Home-Based Dialysis is Becoming a New Paradigm for ESRD Patients, Thus Expanding Patient Options 39
5.3.2 Wearable, Portable Dialysis Machines are the Latest Technology Trend 43
5.4 Global Renal Dialysis Equipment Market Dynamics 44
5.4.1 Market Drivers 45
5.4.2 Restraints 53

6 Renal Dialysis Equipment Market - Segment Analysis 58
6.1 Hemodialysis Machines 59
6.1.1 Global Hemodialysis Machines Market, Revenue ($m), Historic, 2004-2011 59
6.1.2 Global Hemodialysis Machines Market, Revenue ($m), Forecast, 2011-2018 60
6.1.3 Hemodialysis Machines, Market Dynamics 61
6.2 Peritoneal Dialysis Solutions 63
6.2.1 Global Peritoneal Dialysis Solutions Market, Revenue ($m), Historic, 2004-2011 63
6.2.2 Global Peritoneal Dialysis Solutions Market, Revenue ($m), Forecast, 2011-2018 64
6.2.3 Peritoneal Dialysis Solutions, Market Dynamics 65
6.2.4 Market Restraints 67
6.3 Continuous Renal Replacement Therapy (CRRT) Machines 69
6.3.1 Continuous Venovenous Hemofiltration (CVVH) 69
6.3.2 Continuous Venovenous Hemodiafiltration (CVVHDF) 69
6.3.3 Continuous Venovenous Hemodialysis (CVVHD) 70
6.3.4 Slow, Continuous Ultrafiltration (SCUF) 70
6.3.5 Global Continuous Renal Replacement Therapy Machines Market, Revenue ($m), Historic, 2004-2011 70
6.3.6 Global Continuous Renal Replacement Therapy Machines Market, Revenue ($m), Forecast, 2011-2018 71
6.3.7 Continuous Renal Replacement Therapy, Market Dynamics 72
6.4 Dialysis Accessories 73
6.4.1 AV Fistula Needles 73
6.4.2 Blood Tubing Sets 73
6.4.3 Dialysis Catheters 73
6.4.4 Dialyzers 73
6.4.5 Global Dialysis Accessories Market, Revenue ($m), Historic, 2004-2011 73
6.4.6 Global Dialysis Accessories Market, Revenue ($m), Forecast, 2011-2018 74
6.4.7 Dialysis Accessories, Market Dynamics 75

7 Renal Dialysis Equipment Market by Country, Revenue ($m), 2004 - 2018 77
7.1 Renal Dialysis Equipment Market, The US, Revenue ($m), Historic, 2004-2011 77
7.2 Renal Dialysis Equipment Market, The US, Revenue ($m), Forecast, 2011-2018 78
7.3 Renal Dialysis Equipment Market, Canada, Revenue ($m), Historic, 2004-2011 80
7.4 Renal Dialysis Equipment Market, Canada, Revenue ($m), Forecast, 2011-2018 81
7.5 Renal Dialysis Equipment Market, The UK, Revenue ($m), Historic, 2004-2011 82
7.6 Renal Dialysis Equipment Market, The UK, Revenue ($m), Forecast, 2011-2018 84
7.7 Renal Dialysis Equipment Market, Germany, Revenue ($m), Historic, 2004-2011 85
7.8 Renal Dialysis Equipment Market, Germany, Revenue ($m), Forecast, 2011-2018 86
7.9 Renal Dialysis Equipment Market, France, Revenue ($m), Historic, 2004-2011 87
7.10 Renal Dialysis Equipment Market, France, Revenue ($m), Forecast, 2011-2018 88
7.11 Renal Dialysis Equipment Market, Italy, Revenue ($m), Historic, 2004-2011 89
7.12 Renal Dialysis Equipment Market, Italy, Revenue ($m), Forecast, 2011-2018 90
7.13 Renal Dialysis Equipment Market, Spain, Revenue ($m), Historic, 2004-2011 91
7.14 Renal Dialysis Equipment Market, Spain, Revenue ($m), Forecast, 2011-2018 92
7.15 Renal Dialysis Equipment Market, Japan, Revenue ($m), Historic, 2004-2011 93
7.16 Renal Dialysis Equipment Market, Japan, Revenue ($m), Forecast, 2011-2018 94
7.17 Renal Dialysis Equipment Market, China, Revenue ($m), Historic, 2004-2011 95
7.18 Renal Dialysis Equipment Market, China, Revenue ($m), Forecast, 2011-2018 97
7.19 Renal Dialysis Equipment Market, India, Revenue ($m), Historic, 2004-2011 98
7.20 Renal Dialysis Equipment Market, India, Revenue ($m), Forecast, 2011-2018 99
7.21 Renal Dialysis Equipment Market, Australia, Revenue ($m), Historic, 2004-2011 100
7.22 Renal Dialysis Equipment Market, Australia, Revenue ($m), Forecast, 2011-2018 101
7.23 Renal Dialysis Equipment Market, Brazil, Revenue ($m), Historic, 2004-2011 102
7.24 Renal Dialysis Equipment Market, Brazil, Revenue ($m), Forecast, 2011-2018 104

8 Global Renal Dialysis Equipment Market - Strategic Competitive Assessment 105
8.1 Renal Dialysis Equipment Market, Global, Company Share (%), 2011 105
8.2 Market Opportunities and Risks 106
8.3 Key Market Participants 107
8.3.1 Fresenius Medical Care 107
8.3.2 Baxter International 110
8.3.3 Gambro 112
8.3.4 B. Braun Melsungen 115
8.3.5 Nipro Corporation 116

9 Global Renal Dialysis Equipment Market - Strategic Pipeline Assessment 118
9.1 Pipeline Assessment by Development Stage, 2012 118
9.2 Pipeline Products Summary 118
9.3 Profiles of Key Hemodialysis Machines and Equipment in Clinical Development 119
9.3.1 AFE System 119
9.3.2 Ambulatory Wearable Device 119
9.3.3 Blood Purification Technologies Wearable Artificial Kidney 120
9.3.4 Hemova Port Device 120
9.3.5 Lifeline TEBV - AV Shunt 121
9.3.6 Neutrolin 121
9.3.7 Nocturnal Home Hemodialysis System 122
9.3.8 Optiflow Vascular Anastomotic System 122
9.3.9 Pediatric Renal Dialysis Machine 123
9.3.10 Phraxis InterGraft 123
9.3.11 Prolong AV Graft 124
9.3.12 SelfCare+ 124
9.3.13 Theralite 125
9.3.14 Thixotropic Gel 125
9.3.15 Peritoneal Dialysis Equipment and Accessories, Pipeline Products Summary 126
9.4 Profiles of Key Peritoneal Dialysis Equipment and Accessories Under Clinical Development 126
9.4.1 AWAK 126
9.4.2 Non PVC CAPD 127
9.4.3 Renal Expres 127
9.4.4 Dialysis Accessories, Pipeline Products Summary 128
9.5 Profiles of Key Dialysis Accessories Under Clinical Development 129
9.5.1 Artificial Hemodialysis Access Graft 129
9.5.2 ASPIRE Hemodialysis 129
9.5.3 Biologic Vascular Graft 129
9.5.4 ClearGuard HD 130
9.5.5 CMA 107 Microdialysis Pump 130
9.5.6 CreatiVasc Hemoaccess Valve System 131
9.5.7 dCELL Arterial-Vascular Graft 131
9.5.8 NexSite Hemodialysis Catheter 132
9.5.9 Percutaneous Implant Tool 132
9.5.10 Renaflo II Hemofilter 133
9.5.11 Reversus Hemodialysis Catheter 133
9.5.12 Selective Cytopheretic Device 134
9.5.13 SAFETOUCH AVF Needle 134
9.5.14 Venous Window Needle Guide 135

10 Global Renal Dialysis Equipment Market - Strategic Deal Analysis 136
10.1 Mergers and Acquisitions, 2008-2012 136
10.1.1 Shandong Weigao Group Forms Joint Venture with Terumo Corporation for Peritoneal Dialysis Business 136
10.1.2 Fresenius Medical Care Acquires Hema Metrics’ Crit-Line System Business 136
10.1.3 Fresenius Medical Care Acquires Peritoneal Dialysis Business from Gambro 136
10.2 Partnership Deals, 2008-2012 137
10.2.1 Nephros Enters into Licensing Agreement with Bellco 137
10.2.2 Interface Biologics Enters Into Licensing Agreement with Fresenius Medical Care 137
10.2.3 Fresenius Medical Care Enters into Long-Term Distribution Agreement with Nikkiso 138
10.3 Asset Transaction, 2008-2012 138
10.3.1 Xcorporeal and National Quality Care to Sell Assets to Fresenius USA 138

11 Appendix 139
11.1 Market Definitions 139
11.1.1 Renal Dialysis Equipment 139
11.1.2 Hemodialysis Machines 139
11.1.3 Peritoneal Dialysis Solutions 140
11.1.4 Continuous Renal Replacement Therapy (CRRT) Machines 140
11.1.5 Dialysis Accessories 140
11.2 Abbreviations (in alphabetical order) 140
11.3 Sources 142
11.4 Research Methodology 147
11.4.1 Secondary Research 147
11.4.2 Primary Research 147
11.4.3 Models 148
11.4.4 Forecasts 148
11.4.5 Expert Panel 148
11.5 GlobalData Consulting 148
11.6 Contact Us 148
11.7 Disclaimer 149

List of Tables


Table 1: Prevalence of Co-morbidities by CRF Stage in the US Population Age >20 Years; NHANES, 1999-2006 16
Table 2: Causes of ESRD, the US, 2008 17
Table 3: Incident ESRD Patients by Primary Cause of Diagnosis, Australia, 2007-2010 18
Table 4: Number of ESRD Patients by Country, 2006-2009 19
Table 5: ESRD Incidence and Prevalence Rate (per Million Population) by Country, 2009 20
Table 6: Population-Based Studies of the Prevalence of Chronic Renal Failure in the US 21
Table 7: Incidence of ESRD, Canada, 2006-2009 22
Table 8: Population-Based Studies of CRF Prevalence, Europe 22
Table 9: Annual Intake of New Patients and Incidence of ESRD, Australia, 2006-2010 23
Table 10: ESRD Global Outlook: Number of Dialysis and Kidney Transplant Patients, 2010 24
Table 11: Dialysis Patient Population by Country, 2006-2009 25
Table 12: Dialysis Patients Per 100,000 Population by Country, 2006-2009 26
Table 13: Comparison of CAPD and CCPD Patient Numbers, Global, 2000-2010 34
Table 14: Percent Distribution of Prevalent Dialysis Patients, by Modality, by Country, 2009 36
Table 15: Renal Dialysis Equipment Market, Global, Revenue ($bn), 2004-2011 37
Table 16: Renal Dialysis Equipment Market, Global, Revenue ($bn), 2011-2018 38
Table 17: Percent Prevalence of Dialysis Patients Using Home-based Dialysis Therapies (Home Hemodialysis and Peritoneal Dialysis), 2009 39
Table 18: Pipeline of Wearable, Portable Dialysis Machines 43
Table 19: Diabetes as a Cause of ESRD, Weighted Percentage, by Country, 2002-2010 46
Table 20: Diabetes Prevalence (%) and Patient Population, by Country, 2011 - 2030 47
Table 21: Annual Growth Rate of Total World Population and Elderly Population Aged 60 or Above, Global, 1950-2050 49
Table 22: Observational Studies Favoring Shorter and More Frequent Hemodialysis Sessions 50
Table 23: Number of Dialysis Centers, Global, 2005-2011 52
Table 24: Number of Kidney Transplantation Procedures by Country, 2006-2009 54
Table 25: Functioning Kidney Transplants, Patients per 100,000 Population, by Country, 2006-2009 55
Table 26: Hemodialysis Machines Market, Global, Revenue ($m), 2004-2011 59
Table 27: Hemodialysis Machines Market, Global, Revenue ($m) , 2011-2018 60
Table 28: Possible Complications of Hemodialysis 62
Table 29: Peritoneal Dialysis Solutions Market, Global, Revenue ($bn), 2004-2011 63
Table 30: Peritoneal Dialysis Solutions Market, Global, Revenue ($bn), 2011-2018 64
Table 31: Possible Complications of Peritoneal Dialysis and Their Causes 68
Table 32: Continuous Renal Replacement Therapy Machines Market, Global, Revenue ($m), 2004-2011 70
Table 33: Continuous Renal Replacement Therapy Machines Market, Global, Revenue ($m), 2011-2018 71
Table 34: Dialysis Accessories Market, Global, Revenue ($m), 2004-2011 74
Table 35: Dialysis Accessories Market, Global, Revenue ($m), 2011-2018 75
Table 36: Disadvantages of Dialysis Accessories 76
Table 37: Renal Dialysis Equipment Market, The US, Revenue ($m), 2004-2011 77
Table 38: Renal Dialysis Equipment Market, The US, Revenue ($m), 2011-2018 79
Table 39: Renal Dialysis Equipment Market, Canada, Revenue ($m), 2004-2011 80
Table 40: Prevalent ESRD Patient Numbers by Treatment Modality, Canada, 2000-2009 81
Table 41: Renal Dialysis Equipment Market, Canada, Revenue ($m), 2011-2018 82
Table 42: Renal Dialysis Equipment Market, The UK, Revenue ($m), 2004-2011 83
Table 43: Prevalence Rate (per Million Population), by Treatment Modality, the UK, 2005-2009 83
Table 44: Renal Dialysis Equipment Market, The UK, Revenue ($m), 2011-2018 84
Table 45: Renal Dialysis Equipment Market, Germany, Revenue ($m), 2004-2011 85
Table 46: Renal Dialysis Equipment Market, Germany, Revenue ($m), 2011-2018 86
Table 47: Renal Dialysis Equipment Market, France, Revenue ($m), 2004-2011 87
Table 48: Renal Dialysis Equipment Market, France, Revenue ($m), 2011-2018 88
Table 49: Renal Dialysis Equipment Market, Italy, Revenue ($m), 2004-2011 89
Table 50: Renal Dialysis Equipment Market, Italy, Revenue ($m), 2011-2018 90
Table 51: Renal Dialysis Equipment Market, Spain, Revenue ($m), 2004-2011 91
Table 52: Renal Dialysis Equipment Market, Spain, Revenue ($m), 2011-2018 92
Table 53: Renal Dialysis Equipment Market, Japan, Revenue ($m), Historic, 2004-2011 93
Table 54: Renal Dialysis Equipment Market, Japan, Revenue ($m), 2011-2018 95
Table 55: Renal Dialysis Equipment Market, China, Revenue ($m), 2004-2011 96
Table 56: Renal Dialysis Equipment Market, China, Revenue ($m), 2011-2018 97
Table 57: Renal Dialysis Equipment Market, India, Revenue ($m), 2004-2011 98
Table 58: Renal Dialysis Equipment Market, India, Revenue ($m), 2011-2018 99
Table 59: Renal Dialysis Equipment Market, Australia, Revenue ($m), 2004-2011 100
Table 60: Renal Dialysis Equipment Market, Australia, Revenue ($m), 2011-2018 101
Table 61: Renal Dialysis Equipment Market, Brazil, Revenue ($m), 2004-2011 102
Table 62: Dialysis Patients, Brazil, 2000-2010 103
Table 63: Renal Dialysis Equipment Market, Brazil, Revenue ($m), 2011-2018 104
Table 64: Renal Dialysis Equipment Market, Global, Company Share (%), 2011 105
Table 65: Fresenius Medical Care, Key Marketed Products, 2012 107
Table 66: Baxter International, Key Marketed Products, 2012 111
Table 67: Gambro, Key Marketed Products, 2012 113
Table 68: B. Braun Melsungen, Key Marketed Products, 2012 115
Table 69: Nipro Corporation, Key Marketed Products, 2012 116
Table 70: Hemodialysis Machines and Equipment, Pipeline Products, 2011 118
Table 71: AFE System, Product Status, 2012 119
Table 72: Ambulatory Wearable Device, Product Status, 2012 119
Table 73: Blood Purification Technologies Wearable Artificial Kidney, Product Status, 2012 120
Table 74: Hemova Port Device, Product Status, 2012 120
Table 75: Lifeline TEBV - AV Shunt, Product Status, 2012 121
Table 76: Neutrolin, Product Status, 2012 121
Table 77: Nocturnal Home Hemodialysis System, Product Status, 2012 122
Table 78: Optiflow Vascular Anastomotic System, Product Status, 2012 122
Table 79: Pediatric Renal Dialysis Machine, Product Status, 2012 123
Table 80: Phraxis InterGraft, Product Status, 2012 123
Table 81: Prolong AV Graft, Product Status, 2012 124
Table 82: SelfCare+, Product Status, 2012 124
Table 83: Theralite, Product Status, 2012 125
Table 84: Thixotropic Gel, Product Status, 2012 125
Table 85: Peritoneal Dialysis Equipment and Accessories, Pipeline Products Summary, 2011 126
Table 86: AWAK, Product Status, 2012 126
Table 87: Non PVC CAPD, Product Status, 2012 127
Table 88: Renal Expres, Product Status, 2012 128
Table 89: Dialysis Accessories, Pipeline Products Summary, 2011 128
Table 90: Artificial Hemodialysis Access Graft, Product Status, 2012 129
Table 91: ASPIRE Hemodialysis, Product Status, 2012 129
Table 92: Biologic Vascular Graft, Product Status, 2012 129
Table 93: ClearGuard HD, Product Status, 2012 130
Table 94: CMA 107 Microdialysis Pump, Product Status, 2012 130
Table 95: CreatiVasc Hemoaccess Valve System, Product Status, 2012 131
Table 96: dCELL Arterial-Vascular Graft, Product Status, 2012 131
Table 97: NexSite Hemodialysis Catheter, Product Status, 2012 132
Table 98: Percutaneous Implant Tool, Product Status, 2012 132
Table 99: Renaflo II Hemofilter, Product Status, 2012 133
Table 100: Reversus Hemodialysis Catheter, Product Status, 2012 133
Table 101: Selective Cytopheretic Device, Product Status, 2012 134
Table 102: SAFETOUCH AVF Needle, Product Status, 2012 134
Table 103: NexSite Hemodialysis Catheter, Product Status, 2012 135
Table 104: Renal Dialysis Equipment Market, Global, Acquisition Deals, 2008-2012 136
Table 105: Global Renal Dialysis Equipment Market, Partnership Deals, 2008-2012 137
Table 106: Global Renal Dialysis Equipment Market, Asset Transaction, 2008-2012 138

List of Figures


Figure 1: Types of Renal Failure 11
Figure 2: Stages of Chronic Renal Failure 12
Figure 3: Risk Factors for Chronic Renal Failure 13
Figure 4: Signs and Symptoms of Chronic Renal Failure 14
Figure 5: Prevalence of Co-Morbidities by CRF Stage in the US Population Aged >20 Years; NHANES, 1999-2006 16
Figure 6: Global Incidence and Prevalence of ESRD by Country, 2009 20
Figure 7: Standard Home Hemodialysis-Advantages and Disadvantages 28
Figure 8: Nocturnal Home Hemodialysis- Advantages and Disadvantages 29
Figure 9: Short Daily Home Hemodialysis - Advantages and Disadvantages 29
Figure 10: Advantages and Disadvantages of Home Hemodialysis and In-Center Hemodialysis 30
Figure 11: Advantages and Disadvantages of Continuous Ambulatory Peritoneal Dialysis and Continuous Cyclic Peritoneal Dialysis 33
Figure 12: Comparison of Global Patient Preferences for CAPD and CCPD, 2000-2010 34
Figure 13: Advantages and Disadvantages of Hemodialysis and Peritoneal Dialysis 35
Figure 14: Percent Distribution of Prevalent Dialysis Patients by Modality and Country, 2009 36
Figure 15: Global Renal Dialysis Equipment Market, Revenue ($bn), 2004-2011 37
Figure 16: Global Renal Dialysis Equipment Market, Revenue ($bn), 2011-2018 38
Figure 17: Suitability Criteria for Home Hemodialysis 39
Figure 18: Benefits of Home Hemodialysis 40
Figure 19: Home Hemodialysis Usage Over the Years 41
Figure 20: Medicare Reimbursement for Home Hemodialysis Services and Supplies 43
Figure 21: Global Renal Dialysis Equipment Market Dynamics, Drivers and Barriers 44
Figure 22: DOPPS:Diabetes as a Cause of ESRD, Weighted Percentage by Country, 2002-2010 45
Figure 23: Diabetes Prevalence (%) by Country, 2011 47
Figure 24: Functional and Structural Changes in the Kidneys of the Elderly 48
Figure 25: Annual Growth Rate of Total World Population and Global Population >Age 60, 1950-2050 49
Figure 26: Global Number of Dialysis Centers, 2005-2011 52
Figure 27: Advantages of Kidney Transplantation 53
Figure 28: Patients with Functioning Kidney Transplants per 100,000 Population by Country, 2006-2009 55
Figure 29: Benefits of the UCSF Implantable Artificial Kidney 56
Figure 30: Market Segmentation of Renal Dialysis Equipment, 2011 58
Figure 31: Global Hemodialysis Machines Market, Revenue ($m), 2004-2011 59
Figure 32: Global Hemodialysis Machines Market, Revenue ($m) , 2011-2018 60
Figure 33: Global Peritoneal Dialysis Solutions Market, Revenue ($bn), 2004-2011 63
Figure 34: Global Peritoneal Dialysis Solutions Market, Revenue ($bn), 2011-2018 64
Figure 35: Characteristics of Commercially Available Multibag PD Solutions 66
Figure 36: Characteristics of Commercially Available Single-Bag PD solutions 66
Figure 37: Continuous Renal Replacement Therapies Used in Intensive Care Units 69
Figure 38: Global Continuous Renal Replacement Therapy Machines Market, Revenue ($m), 2004-2011 70
Figure 39: Global Continuous Renal Replacement Therapy Machines Market, Revenue ($m), 2011-2018 71
Figure 40: Short- and Long-Term Benefits of Continuous Renal Replacement Therapy 72
Figure 41: Global Dialysis Accessories Market, Revenue ($m), 2004-2011 73
Figure 42: Global Dialysis Accessories Market, Revenue ($m), 2011-2018 74
Figure 43: Renal Dialysis Equipment Market, The US, Revenue ($m), 2004-2011 77
Figure 44: Renal Dialysis Equipment Market, The US, Revenue ($m), 2011-2018 78
Figure 45: Renal Dialysis Equipment Market, Canada, Revenue ($m), 2004-2011 80
Figure 46: Renal Dialysis Equipment Market, Canada, Revenue ($m), 2011-2018 81
Figure 47: Renal Dialysis Equipment Market, The UK, Revenue ($m), 2004-2011 82
Figure 48: Prevalence Rate (per Million Population) by Treatment Modality, the UK, 2005-2009 83
Figure 49: Renal Dialysis Equipment Market, The UK, Revenue ($m), 2011-2018 84
Figure 50: Renal Dialysis Equipment Market, Germany, Revenue ($m), 2004-2011 85
Figure 51: Renal Dialysis Equipment Market, Germany, Revenue ($m), 2011-2018 86
Figure 52: Renal Dialysis Equipment Market, France, Revenue ($m), 2004-2011 87
Figure 53: Renal Dialysis Equipment Market, France, Revenue ($m), 2011-2018 88
Figure 54: Renal Dialysis Equipment Market, Italy, Revenue ($m), 2004-2011 89
Figure 55: Renal Dialysis Equipment Market, Italy, Revenue ($m), 2011-2018 90
Figure 56: Renal Dialysis Equipment Market, Spain, Revenue ($m), 2004-2011 91
Figure 57: Renal Dialysis Equipment Market, Spain, Revenue ($m), 2011-2018 92
Figure 58: Renal Dialysis Equipment Market, Japan, Revenue ($m), Historic, 2004-2011 93
Figure 59: Renal Dialysis Equipment Market, Japan, Revenue ($m), 2011-2018 94
Figure 60: Renal Dialysis Equipment Market, China, Revenue ($m), 2004-2011 96
Figure 61: Renal Dialysis Equipment Market, China, Revenue ($m), 2011-2018 97
Figure 62: Renal Dialysis Equipment Market, India, Revenue ($m), 2004-2011 98
Figure 63: Renal Dialysis Equipment Market, India, Revenue ($m), 2011-2018 99
Figure 64: Renal Dialysis Equipment Market, Australia, Revenue ($m), 2004-2011 100
Figure 65: Renal Dialysis Equipment Market, Australia, Revenue ($m), 2011-2018 101
Figure 66: Renal Dialysis Equipment Market, Brazil, Revenue ($m), 2004-2011 102
Figure 67: Number of Patients on Dialysis, Brazil, 2000-2010 103
Figure 68: Renal Dialysis Equipment Market, Brazil, Revenue ($m), 2011-2018 104
Figure 69: Global Renal Dialysis Equipment Market , Company Share (%), 2011 105
Figure 70: Global Renal Dialysis Equipment Market, Opportunities and Risks, 2012 106
Figure 71: Fresenius Medical Care, Internal Factors Evaluation 108
Figure 72: Baxter International, Internal Factors Evaluation 111
Figure 73: Gambro, Internal Factors Evaluation 113
Figure 74: B. Braun Melsungen, Internal Factors Evaluation 115
Figure 75: Nipro Corporation, Internal Factors Evaluation 117
Figure 76: Global Renal Dialysis Equipment Market, Pipeline Products by Stage, 2012 118

Upcoming Reports:

Enzyme-Linked Immunosorbent Assay (ELISA) Technologies Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
Enzyme-Linked Immunosorbent Assay (ELISA) is a test performed to detect the presence of antibodies in a biological liquid sample.  ELISA is used as quality control check in many industry and as a diagnostic tool in plant pathology and in medicine.  Though the latest emerging technology i.e. themultiplex proteomic array platform is rapidly replacing the ELISA, its market continues to grow since it is being preferred as a secondary validation tool to confirm the results of multiplex proteomic platform. Emergence of cost effective technologies and laboratory automation are...
Synthetic and Bio-Based Butadiene Market: Industry Overview, Applications and Downstream Potential Opportunities, 2010 - 2018
By - Transparency Market Research
1,3-Butadiene, frequently referred to as butadiene, is a simple conjugated diene with the chemical formula C4H6. It is predominantly used as a monomer for producing synthetic rubber in industries. It is produced as a byproduct of the steam cracking used for producing ethylene and olefins; it is also produced from dehydrogenation of n-butane. The global demand of butadiene has been increasing as main application of butadiene is in the production of acrylonitrile butadiene styrene and styrene butadiene rubber which is basically used for manufacturing automotive tires....
Point Of Sale (POS) Terminals Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts 2012 - 2018
By - Transparency Market Research
Point of sale terminal is a computerized process for replacing cash register. This system is capable of recording and keeping track of customer orders, processing credit and debit cards, connecting to other systems, and managing the inventory. Point of sale terminal has a personal computer as its core which is provided with a specific application program and I/O devices for particular environment. This system is used in various industries including entertainment, restaurants, lodging, and museums requiring point of sale like service desk.   Some of the drivers of...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Scientists Identify Cure for Dengue
Apr 18, 2014  
In a breakthrough discovery that can change the way dengue is treated, scientists have identified a drug target for the deadly dengue viruses. This discovery may help pave the way for discovery of vaccines that can cure this condition that affects nearly 390 million people throughout the world each year.  Scientists have used a new technique for this discovery to show that a region...
India is Facing a Cancer Crisis
Apr 15, 2014  
India is currently facing a cancer crisis – reports a recent research carried out at the King’s college London, in collaboration with the Tata Memorial Cancer Centre, Mumbai.  The reasons estimated for this crisis comprise of increasing rates of smoking, unequal access to proper treatment and belated diagnosis.  Every year, India witnesses around one...
Microparticle Tags to Check Counterfeit Goods Invented
Apr 14, 2014  
Researchers from the Massachusetts Institute of Technology have invented a new set of microparticles that can easily be read by smartphones and establish the authenticity of currency, electronic items and luxury goods.  This strategy is among those countless measures taken by big brands and companies to label their legitimate products in order to stop illegal copies of the...
USFDA Approves Lupins Generic Diabetic Drug
Apr 10, 2014  
The United States Food and Drugs Administration (USFDA) has finally approved Lupin Pharmaceuticals Inc (LPI), the American subsidiary of Indian drug manufacturers Lupin Ltd, to sell Pioglitazone Tablets in the U.S market. The approval has been granted first for fiscal 2015.  Pioglitazone is a generic medicine used for managing diabetes and is a version of Actos tablets...
Infrared Sensors can Soon Be Used to Develop Night-Vision Lenses - A New Discovery Confirms
Apr 8, 2014  
People who fear the dark may soon have a reason to rejoice – an infrared sensor that can eventually be used for mechanizing night-vision lenses has been developed. This effectively means that one can also see through dark with the help of these lenses.  This technology seems possible all due to graphene, a layer of tightly packed carbon atoms that has allowed the creation of...